QA: Indaptus Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001857044_2024_Indaptus_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001857044, Indaptus Therapeutics Inc

  xvar xval
0 AssetsCurrent 13,995,209
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 735
3 remainder_Assets 927,934
4 LiabilitiesCurrent 2,774,032
5 LiabilitiesNoncurrent 73,348
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,756,767
9 ResearchAndDevelopmentExpense 7,621,707
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 955,003
13 remainder_ComprehensiveNetIncome -96,434
  yvar yval
0 Assets 14,923,878
1 Liabilities 2,847,380
2 Expenses 16,378,474
3 Revenues 0
4 StockholdersEquity 12,076,498
5 NetIncome -15,423,471
6 ComprehensiveNetIncome -15,471,688
7 BaseVar 17,600,584
8 EconomicCapitalRatiobeforeLimitedLiability 1.22
9 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time